Swift donated $250,000 to the children's organization Operation Breakthrough, a Kansas City-based nonprofit that supports children living in poverty. The organization is celebrating Swift's ...

Siblings tend to have a unique bond, no matter how different they are. Whether biological, blended, or adopted, sibling love and rivalry can be quite dynamic. That's certainly the case when it ...

Is that Santa's sleigh pulled by a magical herd of reindeer? A bright streak of light in the pre-dawn skies above the U.K. tomorrow morning (Dec. 24) could easily be mistaken for Santa Claus ...

Russia has announced a groundbreaking development in cancer treatment with the creation of an mRNA-based vaccine designed to treat cancer patients. This revolutionary vaccine, set to be launched ...

In a significant medical breakthrough, Russia has reportedly developed an mRNA vaccine against cancer, which will be made available to patients free of cost by 2025. The announcement was made by ...

Still, this doesn't undermine the importance of Willow passing the test, as it represents a breakthrough in quantum computing technology. As of the time of writing, Alphabet's stock has risen ...

This breakthrough could lead to better survival rates and fewer relapses for patients. Scientists at City of Hope, one of the leading cancer research and treatment centers in the U.S., have uncovered ...

A significant breakthrough toward normalization of ties with Saudi Arabia, which will also ease conditions for a hostage deal, was recently achieved, according to a report by Chaim Levinson in the ...

A working group from Israel is in the Qatari capital of Doha this week to re-establish relations with mediators in the event of a breakthrough in negotiations with Hamas, said the officials ...

Pfizer (NYSE:PFE) just dropped some solid news for investors: 2025 revenue projections are right where Wall Street expected, between $61 billion and $64 billion, with adjusted earnings per share ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Sanofi’s BTK inhibitor candidate tolebrutinib for the treatment of adults with nonrelapsing secondary ...